Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
ableto, aid, alleged, Allied, anatomic, Apt, auto, background, BBM, BGH, Bradley, brought, Cancer, Chemistry, CIK, clinical, contrary, Cornell, correct, correspondingly, cytopathology, David, Debenturesuntil, demo, deployment, District, Dr, duration, earlier, Edna, England, ERISA, fail, father, forbearance, Gene, global, guideline, half, hasthe, Hospital, improperly, Index, Indian, inducement, instrategic, interpret, interpretation, inured, KPMG, Laboratory, Lane, language, lending, lengthen, London, Manchester, Medicine, Memorial, Methodist, Michael, move, moved, moving, Mulberry, nineteen, nonpayment, onMay, oTRANSITION, Oxford, package, Pathologist, pathology, pending, Polk, receipt, relocating, repay, reply, rescinded, restructuring, sector, seller, Shore, sixteen, Soilsold, son, South, St, stayed, surgical, Templeton, temporary, travel, trend, UK, unprecedented, unspecified, upside, voluntary, wording, worth, xANNUAL
Removed:
acceleration, acquired, annum, arrangement, authoritative, BioBlend, claim, corroboration, delivered, delivering, enumerated, extension, furnishing, handling, hierarchy, indirectly, installment, Mahoning, mature, measuring, newer, nonfinancial, observable, OPEC, owner, prospective, SouthSide, traditional, transferred, unadjusted, unobservable, UT, venture
Filing tables
Filing exhibits
- 10-K Annual report
- 14.1 Exhibit 14.1 - Code of Ethics
- 21.1 Exhibit 21.1 - List of Subsidiaries
- 23.1 Exhibit 23.1 - Audit Firm Consent
- 24.1 Exhibit 24.1 - Director Power(s) of Attorney
- 31.1 Exhibit 31.1 - CEO Cert
- 31.2 Exhibit 31.2 - CFO Cert
- 32.1 Exhibit 32.1 - CEO Section 906
- 32.2 Exhibit 32.2 - CFO Section 906
- Download Excel data file
- View Excel data file
NVIC similar filings
Filing view
External links
Exhibit 32.1
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Timothy R. Kasmoch, as the Chief Executive Officer of N-Viro International Corporation, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Form 10-K for the year ended December 31, 2013 (the “Form 10-K”) (i) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of N-Viro International Corporation.
/s/ Timothy R. Kasmoch
Timothy R. Kasmoch, President and Chief Executive Officer
June 2, 2014